
    
      The increasing rates of multidrug-resistant (MDR) tuberculosis (TB) are causing great
      concern. The current study that will be conducted at different centers in Germany. Biomarkers
      for treatment response during the course of the tuberculosis therapy will be evaluated. The
      study will be conducted with funding of the German Center for Infection Research (DZIF).
    
  